Cadrenal Therapeutics, Inc. (CVKD) Capital expenditures 2023–2025
Cadrenal Therapeutics, Inc. (CVKD) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$5,104FY2025 · since FY2023: $3,254 → $5,104
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5,104 | -21.9% |
| FY2024 | $6,537 | +100.9% |
| FY2023 | $3,254 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice